Start clinical studies for V590
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 31 Jul 2020
- Due
- 31 Dec 2020
- Delivered
- by 31 Dec 2020
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“V590 is currently in preclinical development and clinical studies are planned to start this year.”
What we found
Evidence strength A What the grades mean
Merck initiated Phase 1 clinical studies for V590 prior to the end of 2020, as evidenced by the company's subsequent review of findings from those studies in early 2021.
-
A Merck & Co., Inc. 10-K filed 2021-02-25
“In January 2021, the Company announced the discontinuation of the clinical development programs for its COVID-19 vaccine candidates, V590 and V591, following Merck’s review of findings from Phase 1 clinical studies for the vaccines.” ✓ confirmed on the page
Market reaction: the shares moved -2.4% against the S&P 500 over the three sessions around the disclosure (24 Feb 2021 to 1 Mar 2021). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Start
- Deliverable
- V590 clinical studies
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Merck & Co., Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-MRK-003173 · Corrections policy